Patients were tracked in a 4-year prospective study until the underlying causality of MCI was clinically diagnosed.
We are excited to announce that ViewMind Inc. will present new results to identify frontotemporal dementia in the MCI stage (prodromal FTD) and to differentiate against Alzheimer’s disease in the MCI stage (prodromal AD).
